financetom
Business
financetom
/
Business
/
Coronavirus curbs have impacted cement supply side: JK Cement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coronavirus curbs have impacted cement supply side: JK Cement
Apr 12, 2021 1:32 AM

More than production, the COVID-19 lockdown has impacted the movement of the cement outside the plant, said Rajnish Kapur, COO at JK Cement on Monday.

Share Market Live

NSE

Speaking to CNBC-TV18, he said, “At this point of time lockdowns have not impacted the production per se in any of our operations. However, what we are now witnessing is on the supply side, where we are now finding some of the cities where the cities have entered into partial kind of lockdown, some places it is night curfew and in some cities especially in MP where the day movement is also not allowed so the movement of the cement outside the plant is something which has got affected.”

On raw material prices, Kapur said, “Raw material cost is a matter of concern, pet coke has risen close to Rs 109-110 percent and today imported pet coke is going higher side of $ 126 per tonne. Similarly, coal prices have increased by 54 percent so these two combined would have an impact of anything about Rs 250 per tonne on the cost of production.”

He further added, “We are actually looking at total power and fuel cost increase of somewhere in the region of Rs 250-275 in the Q1 and Q2 of the coming year. There doesn’t seem to be any indicators at this point in time that the cost is going to go down. There has been a marginal increase in the price of Rs 5-10 in the markets where we operate.”

On industry growth and demand, Kapur said, “As an industry demand we are not that much concerned at this point of time, we feel that the country has got enough to work upon. I am not really saying that the price increase by letting us say Rs 10 kind of price increase is going to have any material impact on the demand. As an industry, we are looking at something between 10 and 12 percent growth in the current FY which has just started.”

Watch the video for the full management commentary

(Edited by : Ajay Vaishnav)

First Published:Apr 12, 2021 10:32 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LL Flooring Shares Rise Pre-Bell After Elections of F9 Board Nominees
LL Flooring Shares Rise Pre-Bell After Elections of F9 Board Nominees
Jul 11, 2024
06:11 AM EDT, 07/11/2024 (MT Newswires) -- LL Flooring Holdings ( LL ) shares were up over 12% in premarket activity Thursday after its shareholders elected all three nominees from the private equity firm F9 Investments. F9 Investments said late Wednesday that based on a preliminary tabulation of voting results, LL Flooring ( LL ) shareholders have elected Tom Sullivan,...
Large distressed Hong Kong realty deals set to rise as more sellers accept losses
Large distressed Hong Kong realty deals set to rise as more sellers accept losses
Jul 11, 2024
HONG KONG, July 11 (Reuters) - Higher-for-longer interest costs and ample retail and office vacancies have pushed the sales of distressed investment properties in Hong Kong higher in the second quarter, a trend realtors expect to continue in an already tepid real estate market. An increasing acceptance among lenders and landlords to book steeper losses has driven up the number...
Novo Nordisk Gets Complete Response Letter from US FDA for Insulin Icodec Application
Novo Nordisk Gets Complete Response Letter from US FDA for Insulin Icodec Application
Jul 11, 2024
06:09 AM EDT, 07/11/2024 (MT Newswires) -- Novo Nordisk ( NVO ) said Wednesday that it has received a complete response letter from the US Food and Drug Administration regarding the company's biologics license application for insulin icodec as treatment of diabetes mellitus. The company said the letter includes requests related to insulin icodec's manufacturing process and its type 1...
Grab's deal to buy smaller Singapore rival could reduce competition, regulator says
Grab's deal to buy smaller Singapore rival could reduce competition, regulator says
Jul 11, 2024
(Reuters) -Singapore-based ride hailing firm Grab's deal to buy smaller rival Trans-cab Holdings is likely to significantly lower competition in the domestic market, the city-state's competition watchdog said on Thursday. Grab is one of Singapore's top ride-hailing firms. The deal is reported to be valued at around S$100 million ($74 million). The Competition & Consumer Commission of Singapore (CCCS) also...
Copyright 2023-2025 - www.financetom.com All Rights Reserved